Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

Background. Highly HLA–sensitized kidney transplant candidates are difficult to desensitize, which reduces their chances of receiving a transplant. Methods. We administered tocilizumab as a monotherapy (8 mg/kg once a mo) to 14 highly sensitized kidney transplant candidates. Highest mean fluorescenc...

Full description

Bibliographic Details
Main Authors: Mélanie Daligault, MS, Béatrice Bardy, MD, Johan Noble, MD, Anne Bourdin, RA, Dominique Masson, MD, Hamza Naciri Bennani, MD, Mathilde Bugnazet, BSB, Paolo Malvezzi, MD, Lionel Rostaing, MD, PhD, Thomas Jouve, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-05-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001139

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001139

Similar Items